Novel genetic loci affecting facial shape variation in humans
- Erasmus MC University Medical Center, Netherlands
- University of Bristol, United Kingdom
- University of Pittsburgh, United States
- King's College London, United Kingdom
- QIMR Berghofer Medical Research Institute, Australia
- University College London, United Kingdom
- CAS-MPG Partner Institute for Computational Biology, China
- Bejing Institute of Genomics, China
- Plastic Surgery Hospital, China
- Cardiff University, United Kingdom
- Instituto Patagonico de Ciencias Sociales y Humanas, Argentina
- Universidade Federal do Rio Grande do Sul, Brazil
- UNAM-Instituto Nacional de Medicina Genomica, Mexico
- Universidad Peruana Cayetano Heredia, Peru
- Universidad de Antioquia, Colombia
- Universidad de Tarapaca, Chile
- Leiden University Medical Center, Netherlands
- Beijing Institute of Genomics, China
Abstract
The human face represents a combined set of highly heritable phenotypes, but knowledge on its genetic architecture remains limited, despite the relevance for various fields. A series of genome-wide association studies on 78 facial shape phenotypes quantified from 3-dimensional facial images of 10,115 Europeans identified 24 genetic loci reaching study-wide suggestive association (p<5x10-8), among which 17 were previously unreported. A follow-up multi-ethnic study in additional 7,917 individuals confirmed 10 loci including 6 unreported ones (padjusted<2.1x10-3). A global map of derived polygenic face scores assembled facial features in major continental groups consistent with anthropological knowledge. Analyses of epigenomic datasets from cranial neural crest cells revealed abundant cis-regulatory activities at the face-associated genetic loci. Luciferase reporter assays in neural crest progenitor cells highlighted enhancer activities of several face-associated DNA variants. These results substantially advance our understanding of the genetic basis underlying human facial variation and provide candidates for future in-vivo functional studies.
Data availability
GWAS meta-analysis summary statistics data of the significantly associated SNPs are provided with the paper in the supplementary file 1. In addition, GWAS meta-analysis summary statistics of all SNPs and all facial phenotypes, including for each SNP the effect allele, non-effect allele and for each phenotype the effect size alligned to the effect allele with standard error and p-value, are made publically available via figshare under https://doi.org/10.6084/m9.figshare.10298396 (updated file). Moreover, after the paper is accepted for publication, we will upload to the EBI GWAS Catalogue the complete summary statistics of all SNPs (same information as on figshare now) into the GWAS Catalogue. We included this information and the website links in the Material and Method section.
Article and author information
Author details
Funding
European Union Horizon 2020 Research and Innovation Programme (740580 (VISAGE))
- Manfred Kayser
Levelhulm Trust (F/07 134/DF)
- Andrés Ruiz-Linares
National Natural Science Foundation of China (91631307)
- Sijia Wang
National Natural Science Foundation of China (91731303)
- Shu-Hua Xu
National Natural Science Foundation of China (30890034)
- Li Jin
Australian NHMRC
- Nicholas G Martin
Australian NHMRC Fellowship (APP1103623)
- Sarah E Medland
National Natural Science Foundation of China (31771388)
- Shu-Hua Xu
National Natural Science Foundation of China (315014)
- Shu-Hua Xu
National Natural Science Foundation of China (31711530331)
- Shu-Hua Xu
National Natural Science Foundation of China (31271338)
- Li Jin
National Science Foundation of China (91651507)
- Fan Liu
National Institute of Dental and Craniofacial Research (R01-DE027023)
- Seth M Weinberg
National Institute of Dental and Craniofacial Research (R01-DE016148)
- Seth M Weinberg
National Institute of Dental and Craniofacial Research (X01-HG007821)
- Seth M Weinberg
Netherlands Organization of Scientific Research (911-03-012)
- M Arfan Ikram
National Key R&D Program of China (2017YFC083501)
- Fan Liu
Strategic Priority Reserach Program Chinese Academy of Sciences (XDC010400100)
- Fan Liu
China Scholarship Council (PhD Fellowship)
- Ziyi Xiong
Netherlands Organization of Scientific Research (1750102005011)
- M Arfan Ikram
Wellcome Trust
- Timothy D Spector
Medical Research Council (102215/2/13/2)
- Evie Stergiakouli
National Institute of Dental and Craniofacial Research (U01-DE20078)
- Seth M Weinberg
The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.
Ethics
Human subjects: All cohort participants gave informed consent and consent to publish. The different cohort studies involved have been approved by their local ethics committees and in part higher institutions such as ministries, as described in the Material and Method section. Protocol numbers can be found for each cohort in the Materials and Methods section.
Copyright
© 2019, Xiong et al.
This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 5,773
- views
-
- 786
- downloads
-
- 63
- citations
Views, downloads and citations are aggregated across all versions of this paper published by eLife.
Download links
A two-part list of links to download the article, or parts of the article, in various formats.
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Novel genetic loci affecting facial shape variation in humans
eLife 8:e49898.
https://doi.org/10.7554/eLife.49898
Further reading
-
- Genetics and Genomics
- Microbiology and Infectious Disease
The ability to analyze the function of all genes in a genome is highly desirable, yet challenging in Leishmania due to a repetitive genome, limited DNA repair mechanisms, and lack of RNA interference in most species. While our introduction of a cytosine base editor (CBE) demonstrated potential to overcome these limitations (Engstler and Beneke, 2023), challenges remained, including low transfection efficiency, variable editing rates across species, parasite growth effects, and competition between deleterious and non-deleterious mutations. Here, we present an optimized approach addressing these issues. We identified a T7 RNAP promoter variant ensuring high editing rates across Leishmania species without compromising growth. A revised CBE single-guide RNAs (sgRNAs) scoring system was developed to prioritize STOP codon generation. Additionally, a triple-expression construct was created for stable integration of CBE sgRNA expression cassettes into a Leishmania safe harbor locus using AsCas12a ultra-mediated DNA double-strand breaks, increasing transfection efficiency by ~400-fold to 1 transfectant per 70 transfected cells. Using this improved system for a small-scale proof-of-principle pooled screen, we successfully confirmed the essential and fitness-associated functions of CK1.2, CRK2, CRK3, AUK1/AIRK, TOR1, IFT88, IFT139, IFT140, and RAB5A in Leishmania mexicana, demonstrating a significant improvement over our previous method. Lastly, we show the utility of co-expressing AsCas12a ultra, T7 RNAP, and CBE for hybrid CRISPR gene replacement and base editing within the same cell line. Overall, these improvements will broaden the range of possible gene editing applications in Leishmania species and will enable a variety of loss-of-function screens in the near future.
-
- Genetics and Genomics
- Neuroscience
Spinal muscular atrophy (SMA) is caused by mutations in the Survival Motor Neuron 1 (SMN1) gene. While traditionally viewed as a motor neuron disorder, there is involvement of various peripheral organs in SMA. Notably, fatty liver has been observed in SMA mouse models and SMA patients. Nevertheless, it remains unclear whether intrinsic depletion of SMN protein in the liver contributes to pathology in the peripheral or central nervous systems. To address this, we developed a mouse model with a liver-specific depletion of SMN by utilizing an Alb-Cre transgene together with one Smn2B allele and one Smn1 exon 7 allele flanked by loxP sites. Initially, we evaluated phenotypic changes in these mice at postnatal day 19 (P19), when the severe model of SMA, the Smn2B/- mice, exhibit many symptoms of the disease. The liver-specific SMN depletion does not induce motor neuron death, neuromuscular pathology or muscle atrophy, characteristics typically observed in the Smn2B/- mouse at P19. However, mild liver steatosis was observed, although no changes in liver function were detected. Notably, pancreatic alterations resembled that of Smn2B/-mice, with a decrease in insulin-producing β-cells and an increase in glucagon-producingα-cells, accompanied by a reduction in blood glucose and an increase in plasma glucagon and glucagon-like peptide (GLP-1). These changes were transient, as mice at P60 exhibited recovery of liver and pancreatic function. While the mosaic pattern of the Cre-mediated excision precludes definitive conclusions regarding the contribution of liver-specific SMN depletion to overall tissue pathology, our findings highlight an intricate connection between liver function and pancreatic abnormalities in SMA.
